+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Mpox Testing Market Outlook 2026-2034: By Method, Specimen, Customer

  • PDF Icon

    Report

  • 160 Pages
  • November 2026
  • Region: Global
  • OG Analysis
  • ID: 6291817
The Mpox Testing Market is estimated at USD 2.0 billion in 2026 and is projected to reach USD 3.0 billion by 2034, growing at a CAGR of 5.2% during 2026-2034.

Market Overview

Mpox testing covers validated analytical workflows and related products, with research-only assays assessed separately. Mpox testing requires appropriate specimens and validated analytical workflows. Amplification and laboratory processing support detection.

Unvalidated alternatives can complicate result interpretation. Qualified supplies support reliable testing. Public-health infrastructure shapes access. Customers compare method capability, sample handling and continuing support. Initial instruments and recurring reagents or consumables can follow different purchasing cycles. Research and routine testing involve different qualification requirements. Laboratories need products that suit their samples and clearly defined analytical objectives. Qualification requires relevant analytical evidence and consistent quality. Clearly documented intended uses and limitations support informed product comparison. Purchasing evaluates supply continuity alongside specifications. Reliable consumables, suitable training and effective service help laboratories maintain their planned workloads. Commercial demand follows the analytical tasks performed, the sample workload and the resources available to sustain reliable laboratory operations.

Key Takeaways

  • Demand drivers: Mpox testing requires appropriate specimens and validated analytical workflows. A larger research field does not automatically create demand for every instrument or assay. Customers compare method capability, sample handling and continuing support.
  • Technology and performance: Amplification and laboratory processing support detection. Calibration, controls and workflow integration influence the quality of usable results. Customers also need clearly defined responsibilities for method setup and continuing service.
  • Challenges and economics: Unvalidated alternatives can complicate result interpretation. Maintenance, repeat measurements and required controls influence the economics of routine analytical work. Application-specific support distinguishes a product that is technically available from a reliable workflow under actual laboratory conditions.
  • Commercial opportunities: Qualified supplies support reliable testing. Application expertise can help customers establish useful workflows. Dependable methods, documentation and continuing support encourage repeat purchasing. Quality records and controlled changes support repeatable work over time.
  • Geographic considerations: Public-health infrastructure shapes access. Research funding and laboratory infrastructure differ between countries. Local technical support and supply access affect practical regional opportunities. Commercial demand follows the analytical tasks performed, the sample workload and the resources available to sustain reliable laboratory operations.
  • Product and segment distinctions: Method coverage includes Validated Molecular Tests, Other Specifically Qualified Tests and Research Assays Assessed Separately. Research and routine testing involve different qualification requirements. Laboratories need products that suit their samples and clearly defined analytical objectives.
  • Application and customer priorities: Specimen categories include Lesion Material and Other Validated Specimens. Qualification requires relevant analytical evidence and consistent quality. Clearly documented intended uses and limitations support informed product comparison. Initial instruments and recurring reagents or consumables can follow different purchasing cycles.
  • Purchasing and delivery: Customers distinguish routine diagnostic methods from research assays. Purchasing evaluates supply continuity alongside specifications. Reliable consumables, suitable training and effective service help laboratories maintain their planned workloads. Qualification requires relevant analytical evidence and consistent quality.
  • Competitive positioning: Roche, Thermo Fisher Scientific and QIAGEN are among the companies covered. The analysis distinguishes relevant product, technology and channel roles, with emphasis on application fit, supply capabilities and customer support.
  • Outlook priorities: The mpox testing outlook depends on the interaction of end-use demand, product qualification and commercially viable delivery. Qualified supplies support reliable testing. Public-health infrastructure shapes access.

Competitive Landscape

The mpox testing competitive landscape includes Roche, Thermo Fisher Scientific, QIAGEN and Seegene, alongside the other companies named in this report. Customers compare method capability, sample handling and continuing support. Initial instruments and recurring reagents or consumables can follow different purchasing cycles. Qualification requires relevant analytical evidence and consistent quality. Clearly documented intended uses and limitations support informed product comparison. Purchasing evaluates supply continuity alongside specifications. Reliable consumables, suitable training and effective service help laboratories maintain their planned workloads. The study compares relevant portfolios and routes to market, separating direct product provision from technology, distribution and service roles where applicable. Strategic assessment focuses on product development, application support and market access without treating every participant as a supplier of identical offerings.

Companies Mentioned

  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • Seegene
  • bioMérieux
  • BD
  • CerTest Biotec
  • Genes2Me
  • Sansure Biotech
  • Aptitude Medical Systems
  • Abbott
  • Bio-Rad Laboratories
  • Hologic
  • DiaSorin
  • TIB Molbiol
  • SD Biosensor
  • Trivitron Healthcare
  • Bioneer

Market Segmentation: Mpox Testing Market

By Method

  • Validated Molecular Tests
  • Other Specifically Qualified Tests
  • Research Assays Assessed Separately

By Specimen

  • Lesion Material
  • Other Validated Specimens

By Customer

  • Clinical Laboratories
  • Public-Health Laboratories
  • Research and Other Facilities

Mpox Testing Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Mpox Testing Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analysed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across the report’s covered markets.

Countries Covered

  • North America - Mpox Testing Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Mpox Testing Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • BeNeLux
    • Russia
    • Sweden

  • Asia-Pacific - Mpox Testing Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Mpox Testing Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Mpox Testing Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru
* We can include data and analysis of additional countries on demand.

Research Methodology

This study combines primary inputs from industry experts across the Mpox Testing value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

  • What are the current market size and outlook across the covered markets?
  • Which product and customer categories offer the most relevant opportunities?
  • How do supply conditions, pricing and competitive strategies affect market development?
  • Which risks and practical investment considerations should decision makers evaluate?

Your Key Takeaways from the Mpox Testing Market Report

  • Global Mpox Testing Market size and growth projections (CAGR), 2026-2034
  • Impact of geopolitical developments on Mpox Testing trade, costs, and supply chains
  • Mpox Testing Market size, share, and outlook across the 5 regions and country/subregional markets listed above, 2026-2034
  • Mpox Testing Market size, CAGR, and market share of key products, applications, and end-user verticals, 2026-2034
  • Short- and long-term Mpox Testing Market trends, drivers, restraints, and opportunities
  • Porter’s Five Forces analysis, technological developments, and Mpox Testing supply chain analysis
  • Mpox Testing trade analysis, Mpox Testing Market price analysis, and Mpox Testing supply/demand dynamics
  • Company profiles covering business overview, key strategies, financial information where available, and relevant products
  • Latest Mpox Testing Market news and developments

This product will be delivered within 1-3 business days.

Table of Contents

1. Mpox Testing Market - Executive Summary
1.1. Market Snapshot, 2026
1.2. Key Findings and Outlook, 2026-2034

2. Mpox Testing Market - Market Scope and Research Methodology
2.1. Product and Service Definitions
2.2. Value Chain and Revenue Boundaries
2.3. Research Methodology and Forecast Assumptions

3. Mpox Testing Market - Market Dynamics
3.1. Drivers, Trends and Opportunities
3.2. Constraints and Challenges

4. Mpox Testing Market - Market Economics
4.1. Pricing and Procurement
4.2. Supply Chain and Relevant Policy Environment

5. Mpox Testing Market - Market Size and Outlook, 2026-2034
5.1. Total Market Revenue
5.2. By Method
5.3. By Specimen
5.4. By Customer

6. Mpox Testing Market - North America Market Outlook
6.1. Regional Revenue and Forecast
6.2. By Method
6.3. By Specimen
6.4. By Customer
6.5. Country Analysis

7. Mpox Testing Market - Asia-Pacific Market Outlook
7.1. Regional Revenue and Forecast
7.2. By Method
7.3. By Specimen
7.4. By Customer
7.5. Country Analysis

8. Mpox Testing Market - Europe Market Outlook
8.1. Regional Revenue and Forecast
8.2. By Method
8.3. By Specimen
8.4. By Customer
8.5. Country Analysis

9. Mpox Testing Market - South and Central America Market Outlook
9.1. Regional Revenue and Forecast
9.2. By Method
9.3. By Specimen
9.4. By Customer
9.5. Country Analysis

10. Mpox Testing Market - Middle East and Africa Market Outlook
10.1. Regional Revenue and Forecast
10.2. By Method
10.3. By Specimen
10.4. By Customer
10.5. Country Analysis

11. Mpox Testing Market - Competitive Landscape
11.1. Companies Mentioned
11.2. Product and Service Portfolios
11.3. Supplier Positioning

12. Mpox Testing Market - Strategic Developments and Outlook
12.1. Technology and Product Developments
12.2. Commercial Opportunities
12.3. Frequently Asked Questions

13. Mpox Testing Market - Appendix
13.1. Definitions and Abbreviations
13.2. Sources and Forecast Assumptions

Companies Mentioned

  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • Seegene
  • bioMérieux
  • BD
  • CerTest Biotec
  • Genes2Me
  • Sansure Biotech
  • Aptitude Medical Systems
  • Abbott
  • Bio-Rad Laboratories
  • Hologic
  • DiaSorin
  • TIB Molbiol
  • SD Biosensor
  • Trivitron Healthcare
  • Bioneer

Table Information